By ARTES Biotechnology…
ARTES presenting at BIO-Europe Stockholm
Langenfeld, Germany: – ARTES Biotechnology, the German-based biopharmaceutical CDMO specializing in development of microbial cell lines for recombinant proteins and vaccines, is returning to participate in Europe’s leading life sciences partnering conference, BIO-Europe 2024, this year in Stockholm for its 30th Anniversary.
ARTES will have an exhibition booth at the conference (149) at the Stockholmsmässan International Fairs Center, which will display its range of cell lines and process development solutions for biopharma products along with its range of laboratory reagents.
Innovative vaccine technology
ARTES will use the numerous networking opportunities at BIO-Europe to attract new interested parties for its service offerings and to present its expertise in microbial cell line and process development. The team will highlight, among other things, the technological advantages of the SplitCore technology, which uses an innovative approach with capsid-like particles (cVLP) for vaccine development, and the patented METAVAX® platform, which was developed for the development of highly immunogenic subunit vaccines.
About ARTES Biotechnology
ARTES Biotechnology GmbH is a German company specialized in the development of processes for the production of recombinant proteins from microbial expression systems. In particular, the company offers the development of optimized production cell lines and processes based on yeast (Hansenula, Pichia, Saccharomyces) and bacteria (E. coli). The expression platforms are complemented by a unique virus-like particle (VLP) technology for antigen presentation and vaccine development. For more than 20 years, ARTES has successfully partnered with human and animal health companies, enzyme manufacturers, and the cosmetics, diagnostics, and nutrition industries. The company operates worldwide from its 945 sqm facility in Langenfeld, Germany.
More information at http://www.artes-biotechnology.com
About BIO-Europe 2024
BIO-Europe® is a premier partnering conference that annually attracts an international “who’s who” of decision-makers from Europe’s biotech, pharma and investment communities for high-caliber networking.
The three-day 2024 event opens November 4 at the Stockholmsmässan Stockholm International Fairs Center in the Swedish capital, followed by two further days of digital partnering on November 12-13.
Featuring a sophisticated partnering system, partneringONE®, the event enables delegates to network with companies across the life science value chain, from large biotech and pharma companies to financiers and innovators.
The 30th Anniversary event is expected to involve up to 5,500 potential partners, representing more than 2,800 companies from around the world, with a conference agenda structured around the headline themes of the Business of Biotech, Therapeutic Insights, and Ecosystem Innovation.
The program also features more than 20 workshops and panels, with thousands of licensing opportunities posted.
The event is organized by Informa Connect with more information at: https://informaconnect.com/bioeurope/